Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AbbVie Inc

TRADE

NYSE: ABBVHealthcare / Drug Manufacturers - Major / USA
98.22+0.77+0.79%Vol 6 306 4211Y Perf 39.39%
Aug 16th, 2018 16:02
BID96.00 ASK98.75
Open97.84 Previous Close97.45
Pre-Market97.45 After-Trading98.20
 - -%  -0.02 -0.02%
Target Price
108.93 
Analyst Rating
Moderate Buy 2.29
Potencial %
10.90 
Finscreener Ranking
★★+     47.60
Insiders Trans % 3/6/12M
33/-76/-89 
Value Ranking
★★     46.27
Insiders Value % 3/6/12M
-49/-95/-97 
Growth Ranking
★★★★     59.48
Insiders Shares Cnt. % 3/6/12M
-47/-94/-97 
Income Ranking
★★     42.82
Market Cap (mil)148 732 
Earnings Rating
Price Range Ratio 52wk %
50.98 
Earnings Date

Today's Price Range

97.0698.65

52wk Range

69.47125.86

5 Year PE Ratio Range

9.9065.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
2.95%
3 Months
-6.74%
6 Months
-17.18%
1 Year
39.39%
3 Years
42.90%
5 Years
145.74%

Quotes

Name / TickerPriceChg.Chg.%
ABBV98.220.77000.79
AAPL213.323.08001.46
GOOG1 206.49-7.8900-0.65
MSFT107.64-0.0200-0.02
XOM78.001.06001.38
WFC58.660.67001.16
JNJ132.482.05001.57
FB174.70-4.8300-2.69
GE12.300.08000.65
JPM114.771.07000.94
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.60
Current Ratio 0.80
Long Term Debt to Total Capital 0.90
Total Debt to Equity 10.49
Interest Coverage 7.60
Leverage Ratio 22.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin74.90
EBIT Margin30.10
EBITDA Margin35.40
Pre-tax Profit Margin25.50
Profit Margin20.84
ValuationValueIndustryS&P 500US Markets
PE Ratio 23.70
PB Ratio 42.01
PS Ratios 4.69
Price to Cash Flow 13.40
Price to Free Cash Flow 26.40
Cash Flow Per Share 7.13
Price to Tangible Book-3.16
Book Value per Share-2.23
Enterprise Value (in ths.)178 433 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)116.90
ROE last 12 Months 487.40
Return on Assets (5Y Avg) 6.92
ROA last 12 Months 9.98
Return on Capital (5Y Avg) 17.46
ROC last 12 Months 18.80
Return on invested Capital Q 5.87
Return on invested Capital Y14.23
Assets Turnover0.20
Receivables Turnover2.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)30 946 000
Revenue per Share 20.44
Revenue Growth 3 Years 10.50
Revenue Growth 5 Years 10.03
DividendsValueIndustryS&P 500US Markets
Dividend Yield 3.97
Dividend Rate 3.84
Dividend Growth 3 Years12.54
Dividend Growth 5 Years18.44

Earnings HistoryEstimateReportedSurprise %
Q02 20181.982.001.01
Q01 20181.801.873.89
Q04 20171.441.482.78
Q03 20171.391.411.44
Q02 20171.401.421.43
Q01 20171.261.281.59
Q04 20161.201.200.00
Q03 20161.211.210.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR1.975.91Positive
9/2018 QR1.993.65Positive
12/2018 FY7.804.42Positive
12/2019 FY8.831.61Positive
Next Report Date27th Jul 2018
Estimated EPS Next Report1.98
Estimates Count8
EPS Growth Next 5 Years %13.80
Volume Overview
Volume6 306 421
Shares Outstanding (in ths.)1 514 270
Trades Count25 034
Dollar Volume379 090 806
Avg. Volume7 654 389
Avg. Weekly Volume5 448 111
Avg. Monthly Volume6 831 708
Avg. Quarterly Volume8 273 815

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (41.18 %)
7 (43.75 %)
9 (52.94 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
9 (52.94 %)
8 (50.00 %)
7 (41.18 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (5.88 %)
1 (6.25 %)
1 (5.88 %)
RatingModerate Buy
2.29
Moderate Buy
2.25
Moderate Buy
2.06

There are no comments yet.

News

x